Matter just got an upgrade
Now smaller, easier to swallow, and methylated for better absorption.
Elysium Health launches an upgraded version of Matter, its daily supplement for long-term brain health, featuring methylated B vitamins and smaller, easier-to-swallow softgels. The updated formula still includes a patented tri-vitamin complex developed in partnership with the University of Oxford. Elysium Health highlights that 92% of physicians would recommend Matter to support brain health.
Read this email as text
for screen readers, or when images don't load
ELYSIUM | Meet the upgraded Matter softgel | Now with methylated B vitamins and a smaller, easier-to-swallow softgel. | Shop Matter
Same proven formula. Newly improved experience.
New | Old
Matter is Elysium’s daily supplement for long-term brain health, developed in partnership with the University of Oxford.
Now it’s been thoughtfully updated with several format advancements.
*92% of physicians would recommend Matter to combat brain aging and support long-term brain health
Methylated B vitamins
Now with methylated folate and methylcobalamin—active forms of folate and vitamin B12 that are ready for the body to use.
Smaller, easier-to-swallow softgels with a distinctive dark blue shell naturally colored by butterfly pea flower extract.
UNIVERSITY OF OXFORD
Developed with the University of Oxford
As always, Matter features a tri-vitamin complex patented and proven to slow brain atrophy associated with aging.
Email headers
sender, ESP fingerprints, unsubscribe and auth headers
As received, minus the delivery side: the archive's own addresses appear as [recipient], relay hops and signatures are left out, and unsubscribe links are trimmed to their host.
- Received-SPF
- pass ([receiver]: domain of [recipient]@send.elysiumhealth.com designates 168.245.121.105 as permitted sender) receiver=[receiver]; client-ip=168.245.121.105; envelope-from="[recipient]@send.elysiumhealth.com"; helo=o1379.shared.klaviyomail.com;
- Authentication-Results
- [receiver]; dkim=pass header.d=elysiumhealth.com header.s=kl2 header.b=oZTX+C3c; dmarc=pass header.from=elysiumhealth.com policy.dmarc=quarantine; spf=none ([receiver]: no SPF records found for [email protected]) smtp.helo=o1379.shared.klaviyomail.com; spf=pass ([receiver]: domain of [recipient]@send.elysiumhealth.com designates 168.245.121.105 as permitted sender) smtp.mailfrom=[recipient]@send.elysiumhealth.com; arc=none smtp.remote-ip=168.245.121.105
- Content-Type
- multipart/alternative; boundary=288bc10fd5fe8b8298738ceb4c72bd845e203d23f97cfa3aa2b75b4da4d6
- Date
- Mon, 03 Aug 2026 13:01:49 +0000 (UTC)
- From
- Elysium Health <[email protected]>
- Mime-Version
- 1.0
- Message-ID
- <-u2emoIRSh2RonIVcN_FIQ@geopod-ismtpd-77>
- Subject
- Matter just got an upgrade
- Reply-To
- [email protected]
- List-Unsubscribe
- <https://manage.kmail-lists.com/…>
- List-Unsubscribe-Post
- List-Unsubscribe=One-Click
- X-Kmail-Account
- R8xQKv
- X-Kmail-Message
- 01KYQWV0SSZWY4205FNVV18WE8
- X-Kmail-Ops
- 01KX28G5HSKQA9CNV085MJW4AC
- X-Report-Abuse
- Please report any spam or abuse to: [email protected]
- X-SG-EID
- u001.Xv32TvI6iuV+tZ4vlqHO3Eyoc9YgexRbkb6TUQjt5r5URa2xXd4QpdRtVy03U1O0JMT4eW4gTO9FDRKIHfZLMIUuHyJr/B/lO+VdUGR8B/XUGoV4AB/jGvz0UlonCFlYdNqMJJEs0Tmpx0hYBjknhDrqL0xbumq84KYb2Bpl23AvVFf2wJGRDQvRX/pa8qWRUwaehq5Dh31QNDLCNZLfkj3QK++gLAnLgIdaOge4ybJSv1t2zOiA0m7i3K7dRkBj
- X-SG-ID
- u001.SdBcvi+Evd/bQef8eZF3BiU3Zi1S53GtqGa3TWBmqe75yn5aYrkvkfG+ZGKrHRvqHEqNnYhXzKEMbIPUuNbUdfpjphyJI24ahdp5cMyD+gtd10HMsYQGG+9KCgoFZ++5Fn6Egwk+p7mtVC630mikNmXy+2OUQKGPQH28ZUdZFkfPaBlaxKvuiXGmcD23DLpGXvIyXP0SqT234cROnHMn7ajmGPbv/w8PWrpkgQFCSeUb7ZH8ANRvl0xnq1IwXMEzfICX0hj0ZXsraiTlYpqCnDPOgbqqy2qY9x2kO6rmTRe58q44Skt4gvyGDd6+VofQlvWh8t5C+jtIhbc7JAmolaWrk9JitCXr30j4zbW53JPK5KJpZSBqoXcQ6Lxmhzdq
- X-Entity-ID
- u001.lP8bpbcNOc7n5/pI/ei+9g==
Archived for reference and commentary. Elysium Health, its logos and content are the property of their respective owners; Inbox Archive claims no affiliation and has disabled all links. If you own this content and would like it removed, get in touch.
Similar campaigns from other brands
Different brands running the same play. Compare any of them side by side.